NCT03494530View on ClinicalTrials.gov

Lixiana Acute Stroke Evaluation Registry

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
Ischemic StrokeAtrial FibrillationHemorrhagic Transformation Stroke
Interventions
DRUG

Edoxaban 60 MG

Anticoagulant used to treat atrial fibrillation

DRUG

Edoxaban 30 mg

Anticoagulant used to treat atrial fibrillation

Trial Locations (1)

T6G2B7

University of Alberta, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT03494530 - Lixiana Acute Stroke Evaluation Registry | Biotech Hunter | Biotech Hunter